Orca1

FDA inspection

Columbia Cosmetics Manufacturing, Inc.: FDA inspection ending Nov 14, 2003

FDA inspection 301526 · Voluntary Action Indicated (VAI) · San Leandro, CA

Key facts

Inspection ID 301526
Firm Columbia Cosmetics Manufacturing, Inc.
FEI number 2919184
Address 1661 Timothy Dr
City San Leandro
State CA
ZIP 94577-2311
Fiscal year 2004
Inspection end date Nov 14, 2003
Classification Voluntary Action Indicated (VAI)
Project area Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation
Product type Drugs, Food/Cosmetics

At a glance

  • 10–99 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections